Ex vivo induction of antitumor DEC-205+ CD11c+ cells in a murine neuroblastoma model by co-stimulation with doxorubicin, lipopolysaccharide and interleukin-4.
Ex vivo induction of antitumor DEC-205+ CD11c+ cells in a murine neuroblastoma model by co-stimulation with doxorubicin, lipopolysaccharide and interleukin-4.
复制标题
通过与阿霉素、脂多糖和白细胞介素 4 共刺激,在小鼠神经母细胞瘤模型中离体诱导抗肿瘤 DEC-205 CD11c 细胞。
DOI:
10.3892/br.2015.546
复制
发表时间:
2016
影响因子:
2.3
通讯作者:
A. Odaka
中科院分区:
文献类型:
--
作者:
Seiichiro Inoue;Y. Setoyama;Y. Beck;Daiki Kitagawa;A. Odaka
The antigen-presenting capacity of specific cells and tumor immunogenicity involved in innate cellular immunity are important for initiating an antitumor response to advanced neuroblastoma. The present study was performed to establish a method of producing antigen-presenting cells that induced an immune response to murine neuroblastoma cells through culture with neuroblastoma cells that had undergone immunogenic cell death. Immunogenic death of neuro-2a murine neuroblastoma cells was induced by exposure to doxorubicin. Mouse bone marrow cells were cultured in medium containing granulocyte-macrophage colony-stimulating factor, followed by the addition of doxorubicin-treated neuro-2a cells to the culture with or without lipopolysaccharide (LPS) and/or interleukin-4. Subsequently, cluster of differentiation (CD) 8α+ lymphocytes were co-cultured with neuro-2a cells and the adherent bone marrow cells obtained by the above procedure to evaluate CD8α+ lymphocyte proliferation and interferon-γ production. Furthermore, the surface antigen profile of adherent bone marrow cells was analyzed by flow cytometry. When adherent bone marrow cells were treated with LPS and/or interleukin-4, followed by co-culture with CD8α+ lymphocytes and neuro-2a cells, interferon-γ production by the CD8α+ cells increased in response to anti-CD3/CD28 antibody stimulation. CD11c major histocompatibility complex II (MHC II) double-positive cells were increased among adherent cells derived from cultured bone marrow cells. These cells were positive for DEC-205, but not CD8α. These findings suggest that co-culture of bone marrow-derived cells with tumor cells (that have undergone immunogenic death by exposure to doxorubicin) plus stimulation by LPS and interleukin-4 induces antigen-presenting cells that can evoke an immune response to neuroblastoma. Bone marrow-derived DEC-205+ CD11c+ MHC II+ dendritic cells are key antigen-presenting cells in the induction of an immune response following phagocytosis of doxorubicin-treated neuroblastoma cells.
登录
查看更多内容
影响因子:
45.3
作者:
Navid, Fariba;Sondel, Paul M.;Santana, Victor M.
通讯作者:
Santana, Victor M.
DOI:
10.1056/nejmoa0911123
发表时间:
2010-09-30
期刊:
The New England journal of medicine
影响因子:
--
作者:
Yu AL;Gilman AL;Ozkaynak MF;London WB;Kreissman SG;Chen HX;Smith M;Anderson B;Villablanca JG;Matthay KK;Shimada H;Grupp SA;Seeger R;Reynolds CP;Buxton A;Reisfeld RA;Gillies SD;Cohn SL;Maris JM;Sondel PM;Children's Oncology Group
通讯作者:
Children's Oncology Group
影响因子:
4.3
作者:
INABA, K;SWIGGARD, WJ;STEINMAN, RM
通讯作者:
STEINMAN, RM
DOI:
10.1056/nejmra0804577
发表时间:
2010-06-10
期刊:
The New England journal of medicine
影响因子:
--
作者:
Maris JM
通讯作者:
Maris JM